Open Access 01-12-2010 | Poster presentation
Switching to Atripla (EFV/FTC/TDF) from Kivexa (ABC/3TC) plus EFV leads to improved perceptions of treatment: results from the ROCKET 1 study
Published in: Journal of the International AIDS Society | Special Issue 4/2010
Login to get access